DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name ▼ | UniProt ID |
---|---|---|---|---|---|
C0155626 | Acute myocardial infarction | PLA2G15 | 23659 | phospholipase A2 group XV | Q8NCC3 |
C0010346 | Crohn Disease | PLA2G15 | 23659 | phospholipase A2 group XV | Q8NCC3 |
C0848558 | Hypospadias | PLA2G15 | 23659 | phospholipase A2 group XV | Q8NCC3 |
C0016065 | Polyostotic fibrous dysplasia | PLA2G15 | 23659 | phospholipase A2 group XV | Q8NCC3 |
C0014852 | Esophageal Diseases | PLA2G15 | 23659 | phospholipase A2 group XV | Q8NCC3 |
C0678222 | Breast Carcinoma | PLA2G15 | 23659 | phospholipase A2 group XV | Q8NCC3 |
C0018790 | Cardiac Arrest | PLA2G15 | 23659 | phospholipase A2 group XV | Q8NCC3 |
C0553580 | Ewings sarcoma | PLA2G15 | 23659 | phospholipase A2 group XV | Q8NCC3 |
C0701818 | Choledocholithiasis | PLA2G15 | 23659 | phospholipase A2 group XV | Q8NCC3 |
C0020445 | Hypercholesterolemia, Familial | PLA2G15 | 23659 | phospholipase A2 group XV | Q8NCC3 |
C0000768 | Congenital Abnormality | PLA2G15 | 23659 | phospholipase A2 group XV | Q8NCC3 |
C0243026 | Sepsis | PLA2G15 | 23659 | phospholipase A2 group XV | Q8NCC3 |
C0011581 | Depressive disorder | PLA2G15 | 23659 | phospholipase A2 group XV | Q8NCC3 |
C0039103 | Synovitis | PLA2G15 | 23659 | phospholipase A2 group XV | Q8NCC3 |
C4290140 | recurrent myocardial infarction | PLA2G15 | 23659 | phospholipase A2 group XV | Q8NCC3 |
C0014742 | Erythema Multiforme | PLA2G15 | 23659 | phospholipase A2 group XV | Q8NCC3 |
C1704272 | Benign Prostatic Hyperplasia | PLA2G15 | 23659 | phospholipase A2 group XV | Q8NCC3 |
C0030297 | Pancreatic Neoplasm | PLA2G15 | 23659 | phospholipase A2 group XV | Q8NCC3 |
C0007107 | Malignant neoplasm of larynx | PLA2G15 | 23659 | phospholipase A2 group XV | Q8NCC3 |
C0279702 | Conventional (Clear Cell) Renal Cell Carcinoma | PLA2G15 | 23659 | phospholipase A2 group XV | Q8NCC3 |
C0021390 | Inflammatory Bowel Diseases | PLA2G15 | 23659 | phospholipase A2 group XV | Q8NCC3 |
C0206754 | Neuroendocrine Tumors | PLA2G15 | 23659 | phospholipase A2 group XV | Q8NCC3 |
C0035078 | Kidney Failure | PLA2G15 | 23659 | phospholipase A2 group XV | Q8NCC3 |
C2239176 | Liver carcinoma | PLA2G15 | 23659 | phospholipase A2 group XV | Q8NCC3 |
C0014859 | Esophageal Neoplasms | PLA2G15 | 23659 | phospholipase A2 group XV | Q8NCC3 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024